热门资讯> 正文
辉瑞/BioNTech更新了加拿大授权的新冠疫苗
2025-08-19 05:20
- 辉瑞(PFE) 0
- BioNTech(BNTX) 0
- 国际脐带血库(CO) 0
- Health Canada has authorized Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) updated COVID-19 shot for the 2025-26 season.
- The vaccine, which targets the Omicron LP.8.1 variant, will be available in pharmacies beginning in the fall.
- Comirnaty, the brand name of the jab, is for individuals six months and older.
More on Pfizer, BioNTech
- Pfizer: This Is What Bulls Waited For
- Pfizer's Turnaround Has Truly Started (Earnings Update)
- Pfizer Q2: Dividends Speak Louder Than EPS
- Stocks retail investors love the most
- HHS reinstates childhood vaccines task force
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
